# Early Pharmacotherapy Aimed at Neuroplasticity in Autism : Safety and Efficacy

> **NCT00166621** · PHASE1,PHASE2 · COMPLETED · sponsor: **Chugani, Diane C.** · enrollment: 20 (—)

## Conditions studied

- Autism

## Interventions

- **DRUG:** Buspirone

## Key facts

- **NCT ID:** NCT00166621
- **Lead sponsor:** Chugani, Diane C.
- **Sponsor class:** INDIV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** 2005-08
- **Target enrollment:** 20 (—)
- **Last updated:** 2011-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00166621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00166621, "Early Pharmacotherapy Aimed at Neuroplasticity in Autism : Safety and Efficacy". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00166621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*